approved

Приложение 4 на ПЛС от 02.12.2019 г.

Unique identificator:  53fc082b-be08-4af0-9c74-7bdd43f3ba7b

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-12-03 10:29:22
  • Created by: georgi_sivchev
  • Updated at: 2019-12-03 10:29:22
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Lisinopril, Hydrochlorothiazide II-5295/30.06.2009 Co-Linipril, Tablet, 20 mg/12,5 mg, mg, Pack: 30 Актавис EАД, България Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД 10.31 2.06 12.37 6% 0.62 10.93 2.19 13.12 18% 1.86 12.79 2.56 15.35 КЦ-1775/20.09.2010 ; КЦPP-1006/23.07.2012 промяна на обстоятелства КЦ-279/14.11.2008 11.12.2008 11.12.2008 Неактивен 2129
Colistimethate sodium 20170268 Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Дания 59.22 11.84 71.06 4% 2.37 61.59 12.32 73.91 16% 9.48 71.07 14.21 85.28 Протокол №345/22.08.2019 НСР-19168/04.07.2019 19.07.2019 02.08.2019 Активен 16608
Colistimethate sodium 20170268 Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Дания 59.22 11.84 71.06 4% 2.37 61.59 12.32 73.91 16% 9.48 71.07 14.21 85.28 Протокол №345/22.08.2019 НСР-19168/04.07.2019 19.07.2019 02.08.2019 Неактивен 16608
Colistimethate sodium 20170268 Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Дания 59.22 11.84 71.06 4% 2.37 61.59 12.32 73.91 16% 9.48 71.07 14.21 85.28 НСР-19168/04.07.2019 19.07.2019 02.08.2019 Неактивен 16608
Colistimethate sodium 20130166 Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 66.69 13.34 80.03 4% 2.67 69.36 13.87 83.23 16% 10.67 80.03 16.01 96.04 НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018; КП-73/28.09.2018 и НСР-16485/17.08.2018;Протокол №345/22.08.2019 02.11.2018 02.11.2018 Активен 3060
Colistimethate sodium 20130166 Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 66.69 13.34 80.03 4% 2.67 69.36 13.87 83.23 16% 10.67 80.03 16.01 96.04 НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018; КП-73/28.09.2018 и НСР-16485/17.08.2018 02.11.2018 02.11.2018 Неактивен 3060
Colistimethate sodium 20130166 Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 176.53 35.31 211.84 4% 7.06 183.59 36.72 220.31 16% 25 208.59 41.72 250.31 НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018 02.08.2018 02.08.2018 Неактивен 3060
Colistimethate sodium 20130166 Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 66.69 13.34 80.03 4% 2.67 69.36 13.87 83.23 16% 10.67 80.03 16.01 96.04 НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017 02.09.2017 02.09.2017 Неактивен 3060
Colistimethate sodium 20130167/13.05.2013 Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 106.71 21.34 128.05 4% 4.27 110.98 22.2 133.18 16% 17.07 128.05 25.61 153.66 НСР-1875/27.11.2013; КП-104/25.10.2017 и НСР-13346/28.07.2017; НСР-14654/18.12.2017 и НСР-14734/22.12.2017 (предварително изпълнение) 02.12.2017 02.01.2018 Заличен 2243
Colistimethate sodium 20130167/13.05.2013 Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 106.71 21.34 128.05 4% 4.27 110.98 22.2 133.18 16% 17.07 128.05 25.61 153.66 НСР-1875/27.11.2013; КП-104/25.10.2017 и НСР-13346/28.07.2017 02.12.2017 02.12.2017 Неактивен 2243
Colistimethate sodium 20130167/13.05.2013 Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 449.84 89.97 539.81 4% 10 459.84 91.97 551.81 16% 25 484.84 96.97 581.81 НСР-1875/27.11.2013 28.11.2013 28.11.2013 Неактивен 2243
Colistimethate sodium 20130166 Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 176.53 35.31 211.84 4% 7.06 183.59 36.72 220.31 16% 25 208.59 41.72 250.31 НСР-4253/30.07.2014 13.08.2014 13.08.2014 Неактивен 3060
Colistimethate sodium 20130166/13.05.2013 Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 Alvogen IPCo S.àr.l, Люксембург Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания 176.65 35.33 211.98 4% 7.07 183.72 36.74 220.46 16% 25 208.72 41.74 250.46 НСР-1875/27.11.2013 28.11.2013 28.11.2013 Неактивен 3060
Colistimethate sodium 20170247 COLISTIN TZF, powder for solution for injection/infusion and inhalation, 1 000 000, IU, Pack: 20 Tarchomin Pharmaceutical Works "Polfa" S.A., Полша Tarchomin Pharmaceutical Works “Polfa” S.A., Полша 118.46 23.69 142.15 4% 4.74 123.2 24.64 147.84 16% 18.95 142.15 28.43 170.58 Протокол №345/22.08.2019 НСР-17343/30.11.2018 15.12.2018 02.01.2019 Активен 16363
Colistimethate sodium 20170247 COLISTIN TZF, powder for solution for injection/infusion and inhalation, 1 000 000, IU, Pack: 20 Tarchomin Pharmaceutical Works "Polfa" S.A., Полша Tarchomin Pharmaceutical Works “Polfa” S.A., Полша 118.46 23.69 142.15 4% 4.74 123.2 24.64 147.84 16% 18.95 142.15 28.43 170.58 НСР-17343/30.11.2018 15.12.2018 02.01.2019 Неактивен 16363
Colistimethate sodium EU/1/11/747/001 Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), IU, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler Teva B.V., Нидерландия Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия 1645.03 329.01 1974.04 4% 10 1655.03 331.01 1986.04 16% 25 1680.03 336.01 2016.04 Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018;Протокол №345/22.08.2019 НСР-7497/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 02.01.2019 Активен 4102
Colistimethate sodium EU/1/11/747/001 Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), IU, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler Teva B.V., Нидерландия Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия 1645.03 329.01 1974.04 4% 10 1655.03 331.01 1986.04 16% 25 1680.03 336.01 2016.04 Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018;Протокол №345/22.08.2019 НСР-7497/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 02.01.2019 Неактивен 4102
Colistimethate sodium EU/1/11/747/001 Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler Teva B.V., Нидерландия Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия 1645.03 329.01 1974.04 4% 10 1655.03 331.01 1986.04 16% 25 1680.03 336.01 2016.04 Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018 НСР-7497/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 02.01.2019 Неактивен 4102
Colistimethate sodium EU/1/11/747/001 Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler Teva B.V., Нидерландия Penn Pharmaceutical Services Ltd., Обединено кралство; Forest-Tosara Ltd., Ирландия 1645.03 329.01 1974.04 4% 10 1655.03 331.01 1986.04 16% 25 1680.03 336.01 2016.04 Промяна на обстоятелства НСР-12902/08.06.2017 НСР-7497/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 02.07.2017 Неактивен 4102
Colistimethate sodium EU/1/11/747/001 Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler Forest Laboratories UK Ltd., Обединено Кралство Penn Pharmaceutical Services Ltd., Обединено кралство; Forest-Tosara Ltd., Ирландия 1645.03 329.01 1974.04 4% 10 1655.03 331.01 1986.04 16% 25 1680.03 336.01 2016.04 НСР-7497/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 13.11.2015 Неактивен 4102
Colistimethate sodium EU/1/11/747/001 Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler Forest Laboratories UK Ltd., Обединено Кралство Penn Pharmaceutical Services Ltd., Обединено кралство; Forest-Tosara Ltd., Ирландия 1645.03 329.01 1974.04 4% 10 1655.03 331.01 1986.04 16% 25 1680.03 336.01 2016.04 НСР-7497/13.11.2015. (допуска се предварително изпълнение) 13.11.2015 13.11.2015 Неактивен 4102
Capecitabine 20130065 Coloxet, Film coated tablet, 150, mg, Pack: 60 EGIS Pharmaceuticals PLC, Унгария Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Ltd, Малта 32.45 6.49 38.94 4% 1.3 33.75 6.75 40.5 16% 5.19 38.94 7.79 46.73 цената се заличава с решение НСР-6729/16.07.2015 (в сила от 16.08.2015 ) НСР-5517/29.01.2015 12.02.2015 12.02.2015 Заличен 3532
Capecitabine 20130065 Coloxet, Film coated tablet, 150, mg, Pack: 60 EGIS Pharmaceuticals PLC, Унгария Accord Healthcare Limited, Обедине-но кралство; Pharmacare Premium Ltd, Малта 37.14 7.43 44.57 4% 1.49 38.63 7.73 46.36 16% 5.94 44.57 8.91 53.48 НСР-1288/03.10.2013 17.12.2013 17.12.2013 Неактивен 3532
Capecitabine 20130067 Coloxet, Film coated tablet, 500, mg, Pack: 120 EGIS Pharmaceuticals PLC, Унгария Accord Healthcare Limited, Обединено кралство; Pharmacare Premium Ltd, Малта 216.31 43.26 259.57 4% 8.65 224.96 44.99 269.95 16% 25 249.96 49.99 299.95 цената се заличава с решение НСР-6730/16.07.2015 (в сила от 16.08.2015 ) НСР-5518/29.01.2015 12.02.2015 12.02.2015 Заличен 3533
Capecitabine 20130067 Coloxet, Film coated tablet, 500, mg, Pack: 120 EGIS Pharmaceuticals PLC, Унгария Accord Healthcare Limited, Обедине-но кралство; Pharmacare Premium Ltd, Малта 246.34 49.27 295.61 4% 9.85 256.19 51.24 307.43 16% 25 281.19 56.24 337.43 НСР-1288/03.10.2013 17.12.2013 17.12.2013 Неактивен 3533
Showing 3126 to 3151 of 16785 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте